27843267|t|Bacteriology of Urine Specimens Obtained from Men with Symptomatic Benign Prostatic Hyperplasia
27843267|a|Bacteriuria and urinary tract infections are common sequelae of benign prostatic hyperplasia (BPH). Thus, the knowledge of urine bacteriology in men with symptomatic BPH in our environment may play a complementary role in management. To determine the incidence of bacteriuria and the antibiotic sensitivity pattern of bacterial isolates in cultured urine samples of men with symptomatic BPH. This was a 1 year prospective study. All patients who presented with lower urinary tract symptoms due to BPH and who met the inclusion criteria were studied. Urine samples were obtained from the patients for microscopy, culture, and sensitivity following standard protocol. Ninety-four patients were studied. The age range was 53-80 years with a mean of 65.5 ± 7.8 years. Bacterial isolates were noted in 42 (44.7%) patients. Six of these had two different species of bacterial organisms isolated. Escherichia coli noted in 20 (47.6%) specimens was the most common organism isolated while the least common, Providencia species, was noted in 1 (2.4%). The bacterial isolates were mostly sensitive to imipenem, meropenem, and nitrofurantoin, but showed greater resistance to cefuroxime, gentamicin, and ofloxacin. There was no significant difference between the means for age (P = 0.80), duration of symptoms (P = 0.09), and prostate size (P = 0.52) in the patients with and those without bacteriuria. Bacteriuria is a common finding in patients with symptomatic BPH in our setting. The bacterial isolates showed high level of resistance to oral cephalosporins and fluoroquinolones. There is a need to update guidelines in empiric use of antibiotics in this group of patients.
27843267	0	12	Bacteriology	T059	C0555176
27843267	16	31	Urine Specimens	T031	C1610733
27843267	32	40	Obtained	T169	C1301820
27843267	46	49	Men	T098	C0025266
27843267	55	66	Symptomatic	T169	C0231220
27843267	67	95	Benign Prostatic Hyperplasia	T191	C1704272
27843267	96	107	Bacteriuria	T047	C0004659
27843267	112	136	urinary tract infections	T047	C0042029
27843267	141	147	common	T081	C0205214
27843267	148	156	sequelae	T046	C0243088
27843267	160	188	benign prostatic hyperplasia	T191	C1704272
27843267	190	193	BPH	T191	C1704272
27843267	206	215	knowledge	T170	C0376554
27843267	219	224	urine	T031	C0042036
27843267	225	237	bacteriology	T059	C0555176
27843267	241	244	men	T098	C0025266
27843267	250	261	symptomatic	T169	C0231220
27843267	262	265	BPH	T191	C1704272
27843267	273	284	environment	T082	C0014406
27843267	310	314	role	T077	C1705810
27843267	318	328	management	T058	C0030677
27843267	347	356	incidence	T081	C0021149
27843267	360	371	bacteriuria	T047	C0004659
27843267	380	410	antibiotic sensitivity pattern	UnknownType	C0545239
27843267	414	432	bacterial isolates	T123	C3494793
27843267	436	450	cultured urine	T059	C0430404
27843267	451	458	samples	T167	C0370003
27843267	462	465	men	T098	C0025266
27843267	471	482	symptomatic	T169	C0231220
27843267	483	486	BPH	T191	C1704272
27843267	506	523	prospective study	T062	C0033522
27843267	529	537	patients	T101	C0030705
27843267	542	551	presented	T078	C0449450
27843267	557	585	lower urinary tract symptoms	T184	C0574785
27843267	586	592	due to	T169	C0678226
27843267	593	596	BPH	T191	C1704272
27843267	613	631	inclusion criteria	T080	C1512693
27843267	637	644	studied	T062	C2603343
27843267	646	659	Urine samples	T031	C1610733
27843267	665	673	obtained	T169	C1301820
27843267	683	691	patients	T101	C0030705
27843267	696	706	microscopy	T059	C0026018
27843267	708	715	culture	T059	C0430400
27843267	721	732	sensitivity	T081	C1511883
27843267	733	742	following	T079	C0332282
27843267	743	760	standard protocol	T170	C0442711
27843267	774	782	patients	T101	C0030705
27843267	788	795	studied	T062	C2603343
27843267	801	804	age	T032	C0001779
27843267	805	810	range	T081	C1514721
27843267	815	826	53-80 years	T079	C0439234
27843267	834	838	mean	T081	C0444504
27843267	842	858	65.5 ± 7.8 years	T079	C0439234
27843267	860	878	Bacterial isolates	T123	C3494793
27843267	884	889	noted	T080	C4288581
27843267	904	912	patients	T101	C0030705
27843267	935	944	different	T080	C1705242
27843267	945	952	species	T185	C1705920
27843267	956	965	bacterial	T080	C0521009
27843267	966	984	organisms isolated	T034	C0427941
27843267	986	1002	Escherichia coli	T007	C0014834
27843267	1003	1008	noted	T080	C4288581
27843267	1023	1032	specimens	T167	C0370003
27843267	1046	1052	common	T081	C0205214
27843267	1053	1070	organism isolated	T034	C0427941
27843267	1087	1093	common	T081	C0205214
27843267	1095	1114	Providencia species	T007	C1295805
27843267	1120	1125	noted	T080	C4288581
27843267	1143	1161	bacterial isolates	T123	C3494793
27843267	1174	1183	sensitive	T169	C0332324
27843267	1187	1195	imipenem	T109,T195	C0020933
27843267	1197	1206	meropenem	T109,T195	C0066005
27843267	1212	1226	nitrofurantoin	T109,T121	C0028156
27843267	1239	1246	greater	T081	C1704243
27843267	1247	1257	resistance	T169	C4281815
27843267	1261	1271	cefuroxime	T109,T195	C0007562
27843267	1273	1283	gentamicin	T109,T195	C3854019
27843267	1289	1298	ofloxacin	T109,T195	C0028902
27843267	1310	1324	no significant	T033	C1273937
27843267	1325	1335	difference	T080	C1705242
27843267	1348	1353	means	T081	C0444504
27843267	1358	1361	age	T032	C0001779
27843267	1374	1394	duration of symptoms	T079	C0436359
27843267	1411	1424	prostate size	T033	C0426731
27843267	1443	1451	patients	T101	C0030705
27843267	1467	1474	without	T080	C0332288
27843267	1475	1486	bacteriuria	T047	C0004659
27843267	1488	1499	Bacteriuria	T047	C0004659
27843267	1505	1511	common	T081	C0205214
27843267	1512	1519	finding	T033	C0243095
27843267	1523	1531	patients	T101	C0030705
27843267	1537	1548	symptomatic	T169	C0231220
27843267	1549	1552	BPH	T191	C1704272
27843267	1573	1591	bacterial isolates	T123	C3494793
27843267	1599	1603	high	T080	C0205250
27843267	1604	1609	level	T080	C0441889
27843267	1613	1623	resistance	T169	C4281815
27843267	1627	1631	oral	T082	C0442027
27843267	1632	1646	cephalosporins	T109,T195	C3536856
27843267	1651	1667	fluoroquinolones	T109,T121	C0949665
27843267	1680	1684	need	T080	C0027552
27843267	1688	1694	update	T079	C1519814
27843267	1695	1705	guidelines	T170	C0162791
27843267	1709	1716	empiric	T080	C1880496
27843267	1717	1723	use of	T169	C1524063
27843267	1724	1735	antibiotics	T195	C0003232
27843267	1744	1749	group	UnknownType	C0681860
27843267	1753	1761	patients	T101	C0030705